NEW YORK, Nov. 7-Researchers at Celera Diagnostics and the University of California, San Francisco will work together to identify genetic markers for breast cancer, the company said today.
The collaboration is a large-scale disease association study pairing Celera and UCSF's Comprehensive Cancer Center. Celera Diagnostics and the UC president's office Industry-University Cooperative Research Program will jointly pay for the project.
Financial and intellectual property details of the research partnership were not revealed.
For further details, see the company statement.